AAPG
Price:
$30.7
Market Cap:
$20.17B
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL prote...[Read more]
Industry
Biotechnology
IPO Date
2025-01-24
Stock Exchange
NASDAQ
Ticker
AAPG
According to ASCENTAGE PHARMA GROUP INTERNATIONAL’s latest financial reports and current stock price. The company's current ROE is -249.24%. This represents a change of -13.21% compared to the average of -287.18% of the last 4 quarters.
The mean historical ROE of ASCENTAGE PHARMA GROUP INTERNATIONAL over the last ten years is -149.88%. The current -249.24% ROE has changed 66.29% with respect to the historical average. Over the past ten years (40 quarters), AAPG's ROE was at its highest in in the December 2017 quarter at 87.24%. The ROE was at its lowest in in the December 2023 quarter at -866.12%.
Average
-149.88%
Median
-80.04%
Minimum
-1532.08%
Maximum
738.32%
Discovering the peaks and valleys of ASCENTAGE PHARMA GROUP INTERNATIONAL ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 609.12%
Maximum Annual ROE = 738.32%
Minimum Annual Increase = -587.13%
Minimum Annual ROE = -1532.08%
| Year | ROE | Change |
|---|---|---|
| 2024 | -153.46% | -89.98% |
| 2023 | -1532.08% | 609.12% |
| 2022 | -216.05% | 240.95% |
| 2021 | -63.37% | -20.83% |
| 2020 | -80.04% | -51.87% |
| 2019 | -166.28% | -587.13% |
| 2018 | 34.14% | -62.04% |
| 2017 | 89.92% | -87.82% |
The current ROE of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-633.87%
5-year avg
-409.00%
10-year avg
-149.88%
ASCENTAGE PHARMA GROUP INTERNATIONAL’s ROE is greater than Centessa Pharmaceuticals plc (-56.47%), greater than Apogee Therapeutics, Inc. (-34.98%), greater than Celcuity Inc. (-179.00%), greater than Xenon Pharmaceuticals Inc. (-38.50%), greater than CG Oncology, Inc. Common stock (-15.40%), greater than Zai Lab Limited (-27.32%), greater than Legend Biotech Corporation (-30.95%), greater than Ultragenyx Pharmaceutical Inc. (-414.17%), greater than Disc Medicine, Inc. (-31.61%), greater than Soleno Therapeutics, Inc. (-25.88%),
| Company | ROE | Market cap |
|---|---|---|
| -56.47% | $3.97B | |
| -34.98% | $4.14B | |
| -179.00% | $4.90B | |
| -38.50% | $3.45B | |
| -15.40% | $3.35B | |
| -27.32% | $2.21B | |
| -30.95% | $2.56B | |
| -414.17% | $3.52B | |
| -31.61% | $3.54B | |
| -25.88% | $2.83B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ASCENTAGE PHARMA GROUP INTERNATIONAL using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ASCENTAGE PHARMA GROUP INTERNATIONAL or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ASCENTAGE PHARMA GROUP INTERNATIONAL's ROE?
How is the ROE calculated for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?
What is the highest ROE for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?
What is the 3-year average ROE for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?
What is the 5-year average ROE for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)?
How does the current ROE for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) compare to its historical average?